EML4 and squamous cell carcinoma: Characterization of associations between ALK fusion status and clinicopathological variables revealed that EML4-ALK fusions were associated with adenocarcinoma, because fusions were identified in nine cases of adenocarcinoma, two cases of squamous carcinoma, and one case of adenocarcinoma with partial squamous carcinoma components.